JP2014118361A5 - - Google Patents

Download PDF

Info

Publication number
JP2014118361A5
JP2014118361A5 JP2012272828A JP2012272828A JP2014118361A5 JP 2014118361 A5 JP2014118361 A5 JP 2014118361A5 JP 2012272828 A JP2012272828 A JP 2012272828A JP 2012272828 A JP2012272828 A JP 2012272828A JP 2014118361 A5 JP2014118361 A5 JP 2014118361A5
Authority
JP
Japan
Prior art keywords
fsp
vaccination
tumors
msi
endometrium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012272828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014118361A (ja
JP5890769B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012272828A priority Critical patent/JP5890769B2/ja
Priority claimed from JP2012272828A external-priority patent/JP5890769B2/ja
Publication of JP2014118361A publication Critical patent/JP2014118361A/ja
Publication of JP2014118361A5 publication Critical patent/JP2014118361A5/ja
Application granted granted Critical
Publication of JP5890769B2 publication Critical patent/JP5890769B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012272828A 2012-12-13 2012-12-13 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ） Active JP5890769B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012272828A JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012272828A JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015149569A Division JP2016028025A (ja) 2015-07-29 2015-07-29 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）

Publications (3)

Publication Number Publication Date
JP2014118361A JP2014118361A (ja) 2014-06-30
JP2014118361A5 true JP2014118361A5 (https=) 2015-10-15
JP5890769B2 JP5890769B2 (ja) 2016-03-22

Family

ID=51173521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012272828A Active JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）

Country Status (1)

Country Link
JP (1) JP5890769B2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200188496A1 (en) * 2017-06-02 2020-06-18 Arizona Board Of Regents On Behalf Of Arizona State University Universal cancer vaccines and methods of making and using same
HUE061840T2 (hu) * 2017-07-12 2023-08-28 Nouscom Ag Egy univerzális vakcina, amely közös tumor neoantigéneken alapul a mikroszatellita-instabilitás (MSI) rákos megbetegedések megelõzésére és kezelésére

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
AU2003232485A1 (en) * 2002-04-18 2003-10-27 Mtm Laboratories Ag Neopeptides and methods useful for detection and treatment of cancer

Similar Documents

Publication Publication Date Title
Liu et al. pH-sensitive nano-systems for drug delivery in cancer therapy
JP2017006120A5 (https=)
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
MX2011008429A (es) Metodos y composiciones para diagnostico y tratamiento del cancer.
BR112012024590A2 (pt) métodos de reforço da liberação de fármaco e da eficácia de agentes terapêuticos
JP2016528162A5 (https=)
EA201491299A1 (ru) Карбаматные соединения, их получение и применение
WO2012142529A3 (en) Clonal strains of attenuated vaccinia viruses and methods of use thereof
MX2012010244A (es) Composiciones y metodos de tratamiento para enfermedad de parkinson mediante transferencia del gen bndf-flag a traves del poliplex de neurotensina a neuronas dopaminergicas nigrales.
BR112014019459A8 (pt) Proteínas de ligação à cdim e usos das mesmas
EP2898064A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF TISSUE INJURIES AND DISEASES
JO3776B1 (ar) التركيبات الصيدلانية لمثبط CDK4 / 6 ومثبط B-Raf
MX2011008430A (es) Metodos y composiciones para diagnostico y tratamiento del cancer.
TR201909355T4 (tr) Oral uygulama için proton bağlayıcı polimerler.
JP2016519107A5 (https=)
EA201690004A1 (ru) Антитела против lamp1 и конъюгаты антитела и лекарственного средства, а также их применение
MX2019011965A (es) Composiciones de medicamentos a base de peptido de colageno y metodos y dispositivos para su produccion y uso.
RU2016108808A (ru) Терапевтическое применение vegf-c и ccbe1
BR112012026224A2 (pt) métodos para tratar mal de alzheimer e para avaliar a eficácia de uma terapia
WO2020103961A9 (zh) 一种脑部肿瘤靶向肽及其应用
NZ700872A (en) Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma
JP2016535794A5 (ja) 急速崩壊性固体剤形
JP2014118361A5 (https=)
RU2014101462A (ru) Раковый антиген
CY1116088T1 (el) Δοκοζαεξανοϊκος πανθενυλεστερας και χρηση αυτου για θεραπεια και αποτροπη καρδιαγγειακων ασθενειων